+7 (495) 505-52-05

" "





2013-06-04 20:44:47

. . . , . 250 . 2 . (34), , 500 . 2 . - ? ....
2013-05-15 20:22:14

10. 20. ? ...
2013-05-05 12:39:07

! 4 , , - , ?...
2013-04-24 10:50:26

! : , . : + + . , , , . 2- . - , . . . 3 ......
2013-04-18 21:36:56

! . 50 . . : - , - , . . . - . - , , . , . . ......

,
:

. ""

HEADING_TITLE_2
?
??
30 / Pfizer PGM
- / 150
100
0 01% 15 /
50
15% 15 Bayer HealthCare Manufacturing S r L
100
15% 30 Bayer HealthCare Manufacturing S r L
100 200 / IVAX Pharmaceuticals s r o
/ 35
25 N2 /
/ 35
25 /
- / 75
210
0 75% 15 /
610
5 N20
N11
- 15
N4
15
1% 40 -
15
2% 40 -
3 (3 76) N10 / /
2% 25
3 (3 76) N10 / /
138 4 N2 Hisamitsu Pharmaceutical Co Ltd
0 05% 15 Ursapharm Arzneimittel GmbH
6 54 2 N10 Hisamitsu Pharmaceutical Co Ltd
0 1% 15 Ursapharm Arzneimittel GmbH
710 N5 Hisamitsu Pharmaceutical Co Ltd
DD0151 XL
1410 N3 Hisamitsu Pharmaceutical Co Ltd
BZ0151 36
1000 N50 /
1172 44
500 N50 /
198 43
N15
198 36
N72
7 540 N30 Solgar Vitamin and Herb
/ 60100 N20
N60 Sole Pharmaceuticals Ltd
N1
200 N30
16 14 N10
0 5 N2 -
45 29 N5
0 2 N1 -
100/ 200 12 /
20% 5
- 100/ 200 /
100
- 5 N5
50
0 2% 50 - /
N12 GlaxoSmithKline Dungarvan Ltd
25 N50
N12 GlaxoSmithKline Dungarvan Ltd
N30
N24 GlaxoSmithKline Dungarvan Ltd
100 N30
- 1 N1 / - / / Pfizer MFG Belgium N V
50 N30
- 500 N1 / - / / Pfizer MFG Belgium N V
50 N60
500
75 N30
25 -
75 N60
N20
0 05% 10 Teva Czech Industries s r o
N36
0 1% 10 Teva Czech Industries s r o
350
0 1% 10 Teva Czech Industries s r o
N30
30 ES
N50
0 1% 10 Teva Czech Industries s r o
50
- 0 05% 10 / Merckle
160 N20 Salutas Pharma
- 0 1% 10 Merckle
80 N20 Salutas Pharma
40 N30
10 N30 Ranbaxy
- N50
50
/ 250 Rottapharm
5 Aventis Pharma
/ 250 Rottapharm
/ 125
/ 200 Rottapharm
/ 125
/ 250 Rottapharm
- / 125
/ 250 Rottapharm
/ 75
/ 200 Rottapharm
/ 125
N12
/ 75
N1 35
/ 125
2 35
/ 200
3
/ 75
4 50
- 125
4 N20 /
- 75
- N20
5 N5 - /
N3 N20
2 N10 - / -
N2 50 -
N10 -
N3 50
N20 -
N20 /
N50 -
2 N20 /
5 N25 - / Torrent Pharmaceuticals Ltd
50
5 N5 - / Torrent Pharmaceuticals Ltd
N2 N20 /
N20 Torrent Pharmaceuticals Ltd
N3 N20 /
30 N30 Dr R Pfleger Chemische Fabrik GmbH
12 / 250 Unimedic AB
5 N30 Dr R Pfleger Chemische Fabrik GmbH
1 5 Dana d o o
500+2+0 02/ 5 N10 - /
1 5 Dana d o o
200 N30
N20
30
550 N20
3% 30
+ 3 N20
N50 Biologische Heilmittel Heel GmbH
+ N20
10 N15 West Coast Laboratories
+ N20
- 44
100
N50 Biologische Heilmittel Heel GmbH
300 N50 -
18 N30 /
N10 -
2 5/ 60 4 - /
N20 -
N120 - /
100 N30 Alkaloid AD
30 ProfiMed S r l
- / 75
100
20 N4 - /
100
10 N28 Actavis Group
100
- N180
- 100
- N30
100
- N60
100
N60
Interbros GmbH
- 200
Interbros GmbH
- / 150
Interbros GmbH
- 150
75
150
10 N1 /
/ 5 N15 -
N3
200
N3
N30 -
N9
N60 -
- 50 ""
N60 -
N3
N30 PRO MED CS Praha a s
N9
0 1% 3
N3
1% 3
- 50 ""
100
- N3
13 5 N20 ()
- N9
13 5 N500
- N3
70 N20 ()
- 50 ""
N10 TZMO S A
50+12 5+200 N30
N1 TZMO S A
1 N20 /
N10 TZMO S A
1 N20 /
N1 TZMO S A
N45
N10 TZMO S A
3% 20 /
/ 100 TZMO S A
- 3% 20 /
/ 200 TZMO S A
L Intersan SA
// 250 TZMO S A
- / 10 -
N48 TZMO S A
550 N80 - +
N80 TZMO S A
0 5
N15 TZMO S A
0 5
N15 TZMO S A
0 33
N1 TZMO S A
40
6090 N10 TZMO S A
// ( 1) N100
6090 N30 TZMO S A
( 2) N100
6090 5 TZMO S A
150
N30 TZMO S A
/ N120
N10 TZMO S A
N120
N30 TZMO S A
C 100
Medium N30 TZMO S A
/ 70
N10 TZMO S A
200 Laboratoires Boiron
N10 TZMO S A
0 1% 200 - /
N30 TZMO S A
100 /
50
50 /
N20 /
25 /
300 N10
- 0 2% 30 / Teva Czech Industries s r o
30 -
100 N24
/ 75 GlaxoSmithKline
200 N12
/ 75 GlaxoSmithKline
220/5 90 /
75 GlaxoSmithKline
10 Teva Czech Industries s r o
50 GlaxoSmithKline
25 / Teva Czech Industries s r o
50 GlaxoSmithKline
50 / Teva Czech Industries s r o
50 GlaxoSmithKline
N20 Teva Czech Industries s r o
50 GlaxoSmithKline
- 100 Teva Czech Industries s r o
/ 500
60 Laboratorios Liconsa S A
0 05+5/ 10
/ 250 -
30 /
/ 250
N16 /
/ 250 -
N16 / /
/ 250
N16 / /
/ 250 -
N30
10 N7 Lilly del Caribe Inc
2
25 N7 Lilly del Caribe Inc
25/125 120 / GlaxoSmithKline
40 N7 Lilly del Caribe Inc
25/250 120 / GlaxoSmithKline
60 N7 Lilly del Caribe Inc
50/250 60 / GlaxoSmithKline
50 N24
30 N30 Pfizer Italia S r L
N16 / / Reckitt Benckiser
5 N30 Pfizer
N16 / / 6 Reckitt Benckiser
100 N60 Astrazeneca
N24 / Reckitt Benckiser
200 N60 Astrazeneca
N24 / - Reckitt Benckiser
25 N60 Astrazeneca
N24 / - Reckitt Benckiser
200 N60 Astrazeneca
N24 / Reckitt Benckiser
2% 15 - /
N36 / - Reckitt Benckiser
2% 20 /
N36 / - Reckitt Benckiser
235
C N24 / Reckitt Benckiser
/ 236
20 / Famar
SPF30 118
N24 / Reckitt Benckiser
/ 50
- / N2 Dectra Pharm
- / 295
10% 25
295
2 N1
20 N1 Lilly del Caribe Inc
5% 30
20 N2 Lilly del Caribe Inc
N30
20 N4 Lilly del Caribe Inc
500 N30
20 N8 Lilly del Caribe Inc
25 N50
5 N28 Lilly del Caribe Inc
MG+ 1
10 N10
O2 1 5
0 01% 1 N5
O2 0 6
0 025% 2 N5
O2 0 6
0 5% 5
1 5
N20 PharmaNutra s r l
0+ 0 6
2 N30
1 5
- AQUA/ 50 CPR Produktions- und Vertriebs GmbH
0 5
- Sexuality/ 50 CPR Produktions- und Vertriebs GmbH
0 5
XXL ( ) N3+3 CPR Produktions- und Vertriebs GmbH
- 0 25
XXL N3 CPR Produktions- und Vertriebs GmbH
0 5
N12 CPR Produktions- und Vertriebs GmbH
0 5
N3 CPR Produktions- und Vertriebs GmbH
0 25
N12 CPR Produktions- und Vertriebs GmbH
0 25
N3 CPR Produktions- und Vertriebs GmbH
125
N12 CPR Produktions- und Vertriebs GmbH
60
N12 CPR Produktions- und Vertriebs GmbH
N1200
N3 CPR Produktions- und Vertriebs GmbH
N500
50
500 N10
- 100 N14
500 N10
- 100 N20
1% 50 /
- 100 N4
- 500 N50
- 100 N7
20% 1 5 N2
- 25 N4
20% 2 N2 -
- 50 N10
- 20% 5 -
- 50 N14
10% 2 N10 - / -
- 50 N20
100/5 20 / / Pliva Hrvatska d o o
- 50 N7
125 N6 Pliva Hrvatska d o o
100 N30
250 N6 Pliva Hrvatska d o o
N21
250 N6 Pliva Hrvatska d o o
30 N14 Lilly del Caribe Inc
500 N3 Pliva Hrvatska d o o
60 N28 Lilly del Caribe Inc
500 N3 Pliva Hrvatska d o o
160/4 5 120 / Astrazeneca
200/5 16 74 (15) / Pliva Hrvatska d o o
160/4 5 60 / Astrazeneca
200/5 35 573 (37 5) / / Pliva Hrvatska d o o
320/9 60 / Astrazeneca
100 N6
80/4 5 120 / Astrazeneca
50 N2
80/4 5 60 / Astrazeneca
50 N6
10 N30 Salutas Pharma
100 N10
20 N30 Salutas Pharma
100 N2
10 N30
100 N2
20 N30
- 100 N2 Teva Pharmaceutical Works Private Co
N40
- 50 N2 Teva Pharmaceutical Works Private Co
0 025% 10 /
/ 100
0 025% 15 /
N20
0 025% 15 /
1 2
0 025% 15 /
3 6
10 N14
550 N20
4 N14
850 N20
5 N14
4 N20
100
+ B N20
200
N20
20 / /
N20
2 -
N10
10% 25
N20
250 N10
N30
N15 Lotos Pharma
N60
N50 / Bionorica SE
N14 E-PHARMA Trento S p A
50 N1 / - /
N60
2% 1 N10 - /
N90
-OFF 30
N60
-OFF 30
100/5 30 60 / A MENARINI Manufacturing Logistics
1000 N60 -
400 N6 A MENARINI Manufacturing Logistics
500 N60 -
20/ 1 N5 - / /
850 N60 -
25 N20
2 N30
5 N14
4 N30
5 N7
6 N30
5/ 20
2/ 150 Medana Pharma
10 N40
100
- 100
10
- N16
10
- N16 -
15
- 20
15
- 125
10
/ 75

75 +
- 250
1 5 N20 / - /
- 0 2% 100 (70)
100
- 0 2% 15
0 3 N120
- 0 2% 35
10 0 840 21G 5
- 0 2% 50
20 21G 0 840 N5